Inhibition of TGF-β enabled T cell infiltration to tumors and metastatic lesions, facilitated the response to anti-PD-1 and anti-PD-L1 therapy, diminished tumor growth and reduced liver metastasis (110). This evidence concerns the gene CD274 and neoplasm.